Plasma t-tau and p-tau levels may be useful body fluid biomarkers to predict brain aging, and their elevation suggests the possibility of brain aging and an increased risk of neurodegenerative diseases (Level B, Class IIa). The gene discussed is MAPT; the disease is neurodegenerative disease.